KAT2A was shown to acetylate the E2A-PBX homeobox 1 (PBX1) oncoprotein in B-ALL cells that results from the fusion of transcription factor 3 (TCF3)-PBX1 genes, increasing its stability [72]. This evidence concerns the gene KAT2A and acute lymphoblastic leukemia.